Date & Time: Monday, April 15 | 1–5:30pm
Cost: $199 member/$299 non-member
ACPE UAN: 0233-0000-24-001-L01-P
Contact Hours: 4
Activity Type: Application-based
Description:
Obesity, diabetes, NASH, NSCLC, SMA, hemophilia, sickle cell – what do these all have in common? High-impact, trend-driving treatments! Whether it be a costly 1-time dose for a small population, or a specialty treatment for a large population, these treatments likely have a high-impact on your organization and management strategies. Payers, patients, and manufacturers alike are struggling with the challenges of affordability and access to these high-impact, novel therapies.
This educational session and workshop will feature experts in managed care and innovative contracting who will holistically explore different strategies and mechanisms to put a price on uncertainty. Attendees will delve into the evolving trends of high-impact drugs and generate their own potential innovative contracting or value-based agreement solutions as they build their own “value house.” You don’t want to miss this highly engaging and interactive session!
Learning Objectives:
At the completion of this activity, participants should be able to:
- Describe trends of high-impact drugs in the metabolic, oncology, and cell and gene therapy spaces.
- Summarize current and emerging treatments for metabolic conditions, oncology, and cell and gene therapy.
- Identify challenges faced by payers with the rise of novel therapies.
- Identify the value drivers of various stakeholders when it comes to providing coverage of high-impact drugs.
- Discuss potential innovative contracting strategies for high-impact drugs.
- Using a case example, demonstrate the decision-making and selection of an innovative contracting strategy.
Agenda:
- 1 - 1:10pm - Welcome & Introductions
- 1:10 - 1:35pm - Laying the Framework
- Innovative contracting strategies are being implemented daily in the U.S. and across the globe. How can you apply these strategies in your workplace? Gain a better understanding of the “value house” so you’ll be able to build your own!
- 1:35 - 2:40pm - GLP-1s Use is on the Rise: What’s Your Strategy?
- GLP-1s are taking the world by storm, but how and where are they being used? What do the pipeline and utilization trends look like? What solutions can you generate in your “value house?”
- 2:40 - 3pm - Break
- 3 - 4:05pm - Oncology: What's Your Strategy?
- Oncology is changing constantly with new and novel treatment options emerging at a record pace including non-small cell lung cancer (NSCLC). Learn the latest on NSCLC and strategies to manage your oncology drug spend.
- 4:04-5:10pm - Cell and Gene Therapy: What's Your Strategy?
- In this last section, faculty will focus on diseases being impacted by the rise of cell and gene therapies as they guide attendees through potential management strategies.
- 5:10-5:30pm - Wrap-Up and Closing